Oncology pharma stock price

Surface Oncology (SURF) raised $84 million in an IPO on Thursday, April 19th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Goldman Sachs, Cowen and Evercore ISI served as the underwriters for the IPO. This page (NASDAQ:SURF) was last updated on 5/14/2024 by MarketBeat.com Staff.

The historical data and Price History for Oncology Pharma Inc (ONPH) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. ... For dynamically-generated tables (such as a Stock or ETF Screener) where you see more than 1000 rows of data, the download will be limited to only the first 1000 records on the table. For ...At Shorla Oncology we develop and commercialize innovative oncology drugs. We ... Shorla Pharma Ltd trading as Shorla Oncology®. US OFFICE: 245 Main St., 2nd ...Oncology Pharma Stock (ONPH) Price Forecast for 2024. Our forecast for ONPH stock price in 2024 now indicates an average price target of $ 1.5481 with a high forecast of $ 2.70 and a low forecast of $ 0.3962. The average prediction reflects an increase of +154810534.33% from the last recorded price of $ 0.000001. Month.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock analysis for Oncology Pharma Inc (ONPH:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.View the latest Oncology Pharma Inc. (ONPH) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Lantern Pharma is leveraging A.I., machine learning & genomics to transform the cost, pace, and timeline of oncology drug discovery and development. See how we are doing it. 01. 02. 03. A Pioneering & World Class Team Dedicated to Creating Novel & Breakthrough Precision Oncology Therapies.The biopharmaceutical company earned $42.60 million during the quarter, compared to analysts' expectations of $32.36 million. Loxo Oncology had a negative trailing twelve-month return on equity of 16.42% and a negative net margin of 43.49%. During the same quarter last year, the business posted ($0.94) EPS.Today's High; $0.84: Today's Low; $0.80: 52 Week High; $1.85: 52 Week Low; $0.41. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed.When you place a limit order, you are essentially setting a "limit" on the price you are willing to pay (or receive) for the stocks. For example, if you want to buy shares of Oncology Pharma, you could place a limit order to buy at $0.0001 per share. If the price of Oncology Pharma drops to $0.0001 or less, your order will be executed.What is Cg Oncology Inc. share price today? Cg Oncology Inc. (CGON) share price today is $30.02. Can ...KYMR Kymera Therapeutics, Inc. 37.90. -1.84%. Find the latest Tarsus Pharmaceuticals, Inc. (TARS) stock quote, history, news and other vital information to help you with your stock trading and ...

Oct 25, 2023 · Between in or about January and July 2021, Oncology Pharma, Inc. was a thinly traded company that traded on the over-the-counter securities market. In January 2021, Padilla engaged in manipulative trading in ONPH designed, at least in part, to artificially drive up the company’s stock price. NKTX Nkarta, Inc. 6.25. -0.79%. Find the latest Fusion Pharmaceuticals Inc. (FUSN) stock quote, history, news and other vital information to help you with your stock trading and investing.0.41%. $91.1B. Astellas Pharma Inc. -1.11%. ¥2.75T. OLMA | Complete Olema Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest Astellas Pharma Inc. (ALPMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Thinking about buying or selling stock in ONPH? See the latest Oncology Pharma Inc (ONPH) stock analysis, price, forecast, news and more.

Alvin kamara or jerome ford.

Company profile for Oncology Pharma Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ONPH description & address.Oncology Pharma Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ONPH stock price.Real time Oncology Pharma (ONPH) stock price quote, stock graph, news & analysis.Discover all the factors affecting Race Oncology's share price. RAC is currently rated as a Neutral | Stockopedia.

SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) With much anticipation, Oncology Pharma, Inc. News. ... so why is the stock price plunging? Motley Fool.Inozyme Pharma (INZY) raised $75 million in an initial public offering on Friday, July 24th 2020. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Securities, Cowen and Piper Sandler acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.Little-known pharmaceutical company Oncology Pharma ( OTCPK:ONPH +1.5%) has climbed nearly 4,000% as indicated by the graph. As of Friday, the stock had gained ~4,620.9% year-to-date. According to ...According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Between in or about January and July 2021, Oncology Pharma, Inc. was a thinly traded company that traded on the over-the-counter securities market. In January 2021, Padilla engaged in manipulative trading in ONPH designed, at least in part, to artificially drive up the company’s stock price. Thereafter, Padilla facilitated the sale of ... In depth view into ONPH (Oncology Pharma) stock including the latest price, news, dividend history, earnings information and financials. Oncology Pharma Inc (ONPH) 0.0005 USD | OTCM | Apr 16, 16:00 Current Stock Price for Oncology Pharma (ONPH)? A. The stock price for Oncology Pharma ( OTCEM: ONPH) is $ 0.000001 last updated May 8, 2024, 10:33 AM EDT. Q.6 brokers have issued 1-year price objectives for ALX Oncology's stock. Their ALXO share price targets range from $11.00 to $27.00. On average, they predict the company's share price to reach $18.83 in the next twelve months. This suggests a possible upside of 22.1% from the stock's current price.Get the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Share Price History ; 13 May, 2024, $1.55, +0.14, +9.93%, $1.425 ; 10 May, 2024, $1.41, +0.095, +7.22%, $1.315.

Get the latest Olema Pharmaceuticals Inc (OLMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Sep 26, 2011 ... phase 3 clinical trials; investments; medical oncology; united states food and drug administration; pharmaceutical company; negative studies.Real-time Price Updates for Oncology Pharma Inc (ONPH), along with buy or sell indicators, analysis, charts, historical performance, news and moreFind the latest ORIC Pharmaceuticals, Inc. (ORIC) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Oncology Pharma Inc. | Other OTC: ONPH | Other OTC 58e00334ce83862a341a.s2EFCVndBk2f0B_FK2O_clnlU643duxTIbf4W5bJsj0.5CZqXj6ubX34kmmnflTYFmy_NJtUHYcedY-vFuSBgXnkKmBhDelyLqiIcAFind the latest Syndax Pharmaceuticals, Inc. (SNDX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Kura Oncology, Inc. 20.61-0.48% ...Oncology Pharma Inc () Stock Market info Recommendations: Buy or sell Oncology Pharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Oncology Pharma share forecasts, stock quote and buy / sell signals below.According to present data Oncology Pharma's ONPH shares and potentially its …Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn Pharmaceutical Technology • 13 days ago Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO PharmaceuticalGet real-time updates on Oncology Pharma (ONPH) stock quotes, trades, and more. Make informed investments with Nasdaq.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.

Drunken noodles crosby.

Urgent care hopkinsville ky.

Oncology Pharma (ONPH) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Thinking about buying or selling stock in ONPH? See the latest Oncology Pharma Inc (ONPH) stock analysis, price, forecast, news and more.Research CG Oncology's (Nasdaq:CGON) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... Catalyst Pharmaceuticals. NasdaqCM:CPRX US$1.9b. Agios Pharmaceuticals. NasdaqGS:AGIO US$1.9b. NewAmsterdam Pharma. NasdaqGM:NAMS US$1.9b. …3.1933. +1.05%. Interactive Chart for Oncology Pharma Inc. (ONPH), analyze all the data with a huge range of indicators.Oncology Pharma Inc (ONPH) stock is trading at $24.82 as of 10:27 AM on Friday, Jul 23, a rise of $1.31, or 5.57% from the previous closing price of $23.51. The stock has traded between $23.51 and $26.00 so far today. Volume today is low. So far 47,205 shares have traded compared to average volume of 283,619 shares. Thinking about buying or selling stock in ONPH? See the latest Oncology Pharma Inc (ONPH) stock analysis, price, forecast, news and more. At first glance, the list of cancer drug makers predicted to head the field by 2024 may not look so different from the list of top-selling cancer drug makers in 2017. The cast of characters is ...According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Find the latest BridgeBio Pharma, Inc. (BBIO) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock split history for Oncology Pharma since . Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.Discover real-time Clovis Oncology (CLVSQ) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. ….

153 of 252. Current Quarter EPS Est: NA. Find out the current price target and stock forecast for Oncology Pharma (ONPH)Real time Oncology Pharma (ONPH) stock price quote, stock graph, news & analysis.Are you an oncology nurse looking to expand your knowledge and advance your career? Look no further than free online oncology nursing CEU courses. Online learning has revolutionize...Published Jan. 24, 2024. Gwendolyn Wu Reporter. JaysonPhotography via Getty Images. Cancer drug developer CG Oncology has raised $380 million in an initial public offering than was larger than it expected, a positive sign for a sector that’s struggled to generate demand from Wall Street investors recently.Find the latest Elevation Oncology, Inc. (ELEV) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Vincerx Pharma, Inc. 0.7646 +1.18% ...Oncology Pharma Inc. (ONPH.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Oncology Pharma Inc. | OTC Markets: ONPH | OTC MarketsReal-time Price Updates for Oncology Pharma Inc (ONPH), along with buy or sell indicators, analysis, charts, historical performance, news and moreLast Updated: Apr 26, 2024 2:18 p.m. EDT Delayed quote. $ 0.0600. 0.0600 599,900.00%. Previous Close. $0.0000. Oncology Pharma Inc. advanced stock charts by MarketWatch. View ONPH historial stock ...Today's High; $0.84: Today's Low; $0.80: 52 Week High; $1.85: 52 Week Low; $0.41. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Oncology pharma stock price, [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1]